2006
DOI: 10.1016/j.bbr.2006.01.014
|View full text |Cite
|
Sign up to set email alerts
|

An animal model of capsular infarct: Endothelin-1 injections in the rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
95
1
1

Year Published

2008
2008
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 77 publications
(98 citation statements)
references
References 25 publications
1
95
1
1
Order By: Relevance
“…[10][11][12][13]30 However, lasting pure-motor deficits after a strategically located lesion have never been demonstrated. In one study, 12 motor deficits were limited to a modest twofold increase in foot-faults, and sensory deficits were more prominent, possibly due to the lesion placement in anterior dorsal internal capsule. In another study in hypertensive rats, 13 lesions were smaller, and motor deficits were once again very mild (cylinder test asymmetry index~1.5) and limited to the forelimb (walking ladder test score~5.3 on a scale of 0 worst to 6 best).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[10][11][12][13]30 However, lasting pure-motor deficits after a strategically located lesion have never been demonstrated. In one study, 12 motor deficits were limited to a modest twofold increase in foot-faults, and sensory deficits were more prominent, possibly due to the lesion placement in anterior dorsal internal capsule. In another study in hypertensive rats, 13 lesions were smaller, and motor deficits were once again very mild (cylinder test asymmetry index~1.5) and limited to the forelimb (walking ladder test score~5.3 on a scale of 0 worst to 6 best).…”
Section: Discussionmentioning
confidence: 99%
“…11 The ET-1 model has been used to produce capsular lesions in rats. 12,13 However, deficits have been mild and short-lasting, limiting the usefulness of such models for recovery paradigms.…”
Section: Introductionmentioning
confidence: 99%
“…The direct injection of vasoconstrictor agents into the subcortical white matter has been used to induce focal white-matter stroke both in rats and in mice. [35][36][37] For example, when endothelin-1 is injected into the internal capsule in rats, tissue necrosis and demyelination occur in 14 days, which eventually causes sensorimotor deficits. 35 Also in mice, microinjection of endothelin-1 into the subcortical white matter produces an infarct core as in human subcortical stroke, which accompanies with oligodendrocyte apoptosis, myelin loss, axonal fiber loss, and activation of microglia/ macrophages.…”
Section: Rat/mouse Model Of Focal Injection Of Vasoconstrictormentioning
confidence: 99%
“…Although many studies of therapeutic strategies have been performed using cortical infarct models, only a few studies have investigated subcortical capsular infarcts (SCIs), owing to a lack of pertinent rodent models for capsular infarct. [6][7][8] Specifically, to investigate motor deficits and their recovery after a stroke, a portion of the motor pathway from the motor cortex to the medullary pyramid should be selectively destroyed or modified to create animal models that have motor impairment. However, most of these models involve damage within the gray matter of the cortex, and only a few studies have attempted to damage the white matter to develop a stroke model.…”
Section: Introductionmentioning
confidence: 99%
“…6,7 Only a few models have been successful in manifesting a persistent and marked sensorimotor deficit after SCI. [6][7][8] During the last decade, it has been a challenge to create a persistent SCI model. Several methods have been developed and tested, including occlusion of the middle cerebral artery, occlusion of the anterior choroidal artery, and injection of the vasoconstrictive peptide endothelin-1 into the PLIC.…”
Section: Introductionmentioning
confidence: 99%